Company: MYGN
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0000899923-25-000028
Chunk: 6

Company: MYRIAD GENETICS INC
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 6
---
 in 2023, and more than 4,500 locations in 2024. Notably, we initiated a collaboration with Flatiron Health where physicians can now order our MyRisk ® Hereditary Cancer Test and access results directly within Flatiron’s cloud-based EMR platform, OncoEMR. Additionally, we announced an agreement with Lumea Inc. to integrate Prolaris ® and MyRisk tests into Lumea's digital pathology platform to streamline the ordering and delivery of the tests.

Commitment to Sustainability and Corporate Responsibility

#### Caring and Belonging
Our objective is to make Myriad Genetics a place where all employees have a sense of belonging. We support a culture of caring and inclusion aligned with our company mission, vision, and values to drive company performance by creating opportunities and experiences for learning, development, and a sense of belonging for all employees. We have seven employee-led resource groups that represent and support diverse communities in our workforce. As of December 31, 2024, approximately 64% of our employees were women, and women held 39% of Myriad leadership roles (vice president and above). Approximately one third of the members of our Board of Directors (the "Board") are women, including the chairperson, and 44% of our Board members come from diverse gender, ethnic, and cultural backgrounds.

#### Sustainability
Minimizing our environmental impact aligns with our core values. While our footprint is modest, we actively seek sustainable ways to reduce it, sharing our progress in our Quality, Innovation, and Corporate Responsibility (QICR) report, published in 2025. As we grow, we remain committed to enhancing environmental performance and transparency.

#### Governance
In 2024, our Board adopted a new Clawback Policy that complies with the rules promulgated by the U.S. Securities and Exchange Commission and the Nasdaq Stock Market LLC. In addition, we have demonstrated a commitment to Board refreshment with the appointment of six new directors in the last five years, including a new director in 2024 and Mr. Raha joining the Board on April 30, 2025.

#### 2025 Annual Meeting of Stockholders
We invite you to participate in our virtual 2025 Annual Meeting of Stockholders, during which you will be able to vote your shares electronically and submit questions.

We will ask you to (1) elect three Class II directors to our Board, (2) ratify the selection of Ernst & Young LLP as our independent registered public